The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 trial of exercise as first-line therapy for hormone receptor (HR)–positive advanced breast cancer (TBCRC 054).
 
Neil Iyengar
Consulting or Advisory Role - AstraZeneca; BD Biosciences; Daiichi Sankyo/Lilly; Genentech/Roche; Gilead Sciences; Novartis; Pfizer; Seagen; SynDevRx; Tersera
Research Funding - American Cancer Society (Inst); Breast Cancer Research Foundation (Inst); Conquer Cancer Foundation (Inst); National Cancer Institute (Inst); Novartis (Inst); SynDevRx (Inst)
 
Jessica Lavery
No Relationships to Disclose
 
Adele Carlson
No Relationships to Disclose
 
Vanessa Castillo
No Relationships to Disclose
 
Sarah Lehman
No Relationships to Disclose
 
Meghan Michalski
No Relationships to Disclose
 
Jenna Harrison
No Relationships to Disclose
 
Alexis Braun
No Relationships to Disclose
 
Jessica Flores
No Relationships to Disclose
 
Su Chun
No Relationships to Disclose
 
Catherine Lee
No Relationships to Disclose
 
Jesus Anampa
No Relationships to Disclose
 
Tarah Ballinger
Honoraria - AstraZeneca; Novartis
Consulting or Advisory Role - Medscape
Speakers' Bureau - Novartis/Ipsen
 
Jennifer Sheng
Consulting or Advisory Role - Dedham Group
Research Funding - Pfizer (Inst)
 
Chaya Moskowitz
No Relationships to Disclose
 
Lee Jones
Stock and Other Ownership Interests - illumiSonics; Pacylex